Education
About Us
Working with TipRanks
Follow Us
Inogen Inc (INGN)
NASDAQ:INGN
INGN Stock Chart & Stats
$6.90
$0.43(4.59%)
At close: 4:00 PM EST
$6.90
$0.43(4.59%)
Day’s Range― - ―
52-Week Range$5.70 - $12.91
Previous CloseN/A
Volume110.44K
Average Volume (3M)175.29K
Market Cap
$184.34M
Enterprise Value$114.92M
Total Cash (Recent Filing)$124.50M
Total Debt (Recent Filing)$18.22M
Price to Earnings (P/E)―
Beta1.18
Next Earnings
Mar 03, 2026EPS Estimate
-0.33Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.20
Shares Outstanding27,148,481
10 Day Avg. Volume170,224
30 Day Avg. Volume175,293
Financial Highlights & Ratios
PEG Ratio0.09
Price to Book (P/B)1.25
Price to Sales (P/S)0.65
P/FCF Ratio-19.40
Enterprise Value/Market Cap0.62
Enterprise Value/Revenue0.33
Enterprise Value/Gross Profit0.71
Enterprise Value/Ebitda-14.22
Forecast
1Y Price Target
$13.00Price Target Upside88.41% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Patient SatisfactionAnalyst highlights a patient-use study showing high user satisfaction with the Aurora masks, with many users finding the nasal pillow option as comfortable or more comfortable than prior masks, which supports adoption.
Product LaunchAnalyst notes the Aurora family of CPAP masks expands INGN's presence in sleep therapy devices and creates a new product revenue channel.
Strategic DiversificationAnalyst views the Aurora launch as part of a broader strategy to diversify into respiratory devices, including potential distribution of flow generators to broaden revenue sources.
Bears Say
Competitive LandscapeAnalyst believes entering the CPAP mask market will be challenging due to strong positions of established competitors, which could limit market share gains.
Profitability PressureAnalyst notes gross margin deterioration, which could constrain profitability if cost or pricing pressures persist.
Inogen News
INGN FAQ
What was Inogen Inc’s price range in the past 12 months?
Inogen Inc lowest stock price was $5.70 and its highest was $12.91 in the past 12 months.
What is Inogen Inc’s market cap?
Inogen Inc’s market cap is $184.34M.
When is Inogen Inc’s upcoming earnings report date?
Inogen Inc’s upcoming earnings report date is Mar 03, 2026 which is in 54 days.
How were Inogen Inc’s earnings last quarter?
Inogen Inc released its earnings results on Nov 05, 2025. The company reported -$0.2 earnings per share for the quarter, beating the consensus estimate of -$0.208 by $0.008.
Is Inogen Inc overvalued?
According to Wall Street analysts Inogen Inc’s price is currently Undervalued.
Does Inogen Inc pay dividends?
Inogen Inc does not currently pay dividends.
What is Inogen Inc’s EPS estimate?
Inogen Inc’s EPS estimate is -0.33.
How many shares outstanding does Inogen Inc have?
Inogen Inc has 27,148,481 shares outstanding.
What happened to Inogen Inc’s price movement after its last earnings report?
Inogen Inc reported an EPS of -$0.2 in its last earnings report, beating expectations of -$0.208. Following the earnings report the stock price went down -8.313%.
Which hedge fund is a major shareholder of Inogen Inc?
Currently, no hedge funds are holding shares in INGN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Inogen Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$13.00 (88.41% Upside)
$13.00 (88.41% Upside)
Blogger Sentiment
Bullish
INGN Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 31.5K Shares
Last Quarter.
Last Quarter.
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-20.40%
12-Months-Change
Fundamentals
Return on Equity
-13.27%
Trailing 12-Months
Asset Growth
0.27%
Trailing 12-Months
Company Description
Inogen Inc
Inogen, Inc. is a medical technology company that specializes in the development and manufacturing of portable oxygen concentrators for patients with chronic obstructive pulmonary disease (COPD) and other respiratory conditions. Founded in 2001 and headquartered in Goleta, California, Inogen operates within the healthcare sector, focusing on innovative solutions that enhance the quality of life for individuals requiring supplemental oxygen. The company offers a range of products, including its flagship Inogen One line of portable oxygen concentrators, which are designed to provide patients with mobility and independence while delivering high-quality oxygen therapy.
INGN Company Deck
INGN Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted consistent revenue growth, strong international B2B performance, and successful product launches, demonstrating positive momentum and strategic execution. However, challenges such as decreased direct-to-consumer sales and rental revenue decline were noted, impacting overall profitability.View all INGN earnings summariesINGN Stock 12 Month Forecast
Average Price Target
$13.00
▲(88.41% Upside)
Technical Analysis
Ownership Overview
2.30% Insiders
16.19% Mutual Funds
18.14% Other Institutional Investors
54.21% Public Companies and
Individual Investors